Atlas Trials

REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

Clinical trial NCT01875081 · COMPLETED

Trial details

NCT number
NCT01875081
Sponsor
Pharmicell Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alcoholic Liver Cirrhosis
Start date
2012-11-01
Primary completion
2016-03-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.